This past Friday, the Cerebain Biotech Corp (OTC: CBBT) stock emerged as one of the notable gainers after it clocked considerable gains.
The stock soared by as high as 47% on the back of the heavy trading volume. While the gains were notable, it should also be noted that there was no news with regards to the company that might have triggered such a strong rally in the stock. Cerebain is involved in the medical technology space and is currently at a developmental stage.
At this point in time, the company is involved in the development of an implantable device that is hardly invasive. On top of that, Cerebain is also working on a synthetic drug solution. Last year, the company also completed the acquisition of PKG Inc. At the same time, Cerebain had also provided an update with regards to its intention of becoming current with the Securities and Exchange Commission. It remains to be seen how the stock performs in the coming week.
Editor and Computer Expert
A hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.